FAIR PHARMA SCORECARD

We believe
that access to medicines is a human right that pharmaceutical companies can do more that they should be held accountable

The Fair Pharma Scorecard ranks pharmaceutical companies on how well their policies and practices reflect a commitment to human rights principles. 

Fair Pharma Scorecard: Covid-19 edition

In a pandemic, no one is safe until everyone is safe. In the early days of the outbreak, billions in public financing were mobilised to support urgently needed research and development on Covid-19 countermeasures. But this public financing did not in practice lead to equitable access to resulting vaccines and therapeutics. 

The 2022 Fair Pharma Scorecard ranks 30 different Covid-19 products produced by 26 companies, based on how closely companies chose to adhere to human rights commitments, transparency, international cooperation, and equality, non-discrimination and equity. Click the boxes to see details of how each company scored, or the button below to see the scorecard overview.

Covid-19 Vaccine
ZF2001 (Zifivax)
0%
Covid-19 Vaccine
BBV152 (Covaxin)
0%
Covid-19 Therapeutic
Amubarvimab & Romlusevimab (Brii-196 & Brii-198)
0%
Covid-19 Vaccine
Ad5-nCoV (Convidecia)
0%
Covid-19 Therapeutic
Regdanvimab (Regkirona)
0%
Covid-19 Vaccine
CIGB-66 (Abdala)
0%
Covid-19 Vaccine
BECOV2D (Corbevax)
0%
Covid-19 Vaccine
Finlay-FR-1 (Soberana 02, Pasteurcovac)
0%
Covid-19 Vaccine
Gam-COVID-Vac (Sputnik V)
0%
Covid-19 Therapeutic
Remdesivir (Veklury)
0%
Covid-19 Vaccine
Ad26.COV2.S/Ad26COVS1 (JCovden)
0%
Covid-19 Vaccine
mRNA-1273 (SpikeVax)
0%
Covid-19 Vaccine
COVAX-19 (SpikoGen)
0%
Covid-19 Vaccine
EpiVacCorona (Aurora-CoV)
0%
Covid-19 Vaccine
DNA SARS CoV-2 vaccine (ZyCov-D)
0%
Covid-19 Therapeutic
Tixagevimab/cilgavimab (Evusheld)
0%
Covid-19 Vaccine
AZD1222 (Covishield/Vaxzevria)
0%
Covid-19 Therapeutic
Baricitinib (Olumiant)
0%
Covid-19 Therapeutic
Bamlanivimab & Etesevimab
0%
Covid-19 Therapeutic
Bebtelovimab
0%
Covid-19 Therapeutic
Molnupiravir
0%
Covid-19 Vaccine
NVX-CoV2373 (Covovax)
0%
Covid-19 Therapeutic
Nirmatrelvir [PF-07321332] (Paxlovid)
0%
Covid-19 Vaccine
BNT162b2 (Comirnaty)
0%
Covid-19 Therapeutic
Casivirimab & imdevimab (REGEN-COV)
0%
Covid-19 Therapeutic
Tocilizumab (Actemra)
0%
Covid-19 Vaccine
VAT-00002 and VAT00008 (Vidprevtyn)
0%
Covid-19 Vaccine
BBIBP-CorV (Covilo)
0%
Covid-19 Vaccine
Vero Cell (CoronaVac)
0%
Covid-19 Therapeutic
Baricitinib (Olumiant)
0%

What do we mean by "Fair Pharma?"

Pharmaceutical companies produce essential medicines. Governments offer them exclusive rights to incentivise the development of medicines, as medical innovation is in the public interest. In return, pharmaceutical companies have a duty to protect this public interest, and not to use market exclusivity to drive up prices to unsustainable levels or to prevent follow-on innovation. The degree to which they respect this duty of care is the degree to which we consider them to meet ‘fair pharma’ principles. 

Methodology

How is the Scorecard ranked? A detailed explanation of our Fair Pharma criteria, scoring methods, and data collection process.

Guidelines

How can companies improve their behaviour? See our guidance on how pharma companies can better adhere to human rights principles.

Policy Recommendations

Policy recommendations that can improve equitable access to vaccines and therapeutics during Covid-19 .